Consortium MEDTEQ+: federal grants and contributions: 3 agreements; $1.7M value; 1 departments; 2 programs.
Assay record ASY-CA-0QJMQEJ1YL · Cite as: Assay Systems, “Consortium MEDTEQ+: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/consortium-medteq/
Accompanying services to Canadian SMEs in the medical technology sector, leading to the definition or strengthening of their commercialization strategy, including the alignment of regulatory and reimbursement strategies in parallel and in synergy with their technology development, with a view to accelerating the adoption of Canadian medical technologies for the benefit of patients and health care systems.
Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian companies for COVID-19 testing,
Coaching services for Canadian medical technology SMEs, leading to the definition or reinforcement of their commercialization strategy, including the alignment of regulatory and reimbursement strategies in parallel and in synergy with their technological development, with a view to accelerated adoption of Canadian medical technologies for the benefit of patients and healthcare systems.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.